Les Médicamenteurs

In the last 10 years, the landscape of the pharmaceutical industry has changed. A handful of multinationals control the manufacture of most of the drugs.

Narrator and director Michael Schaap's confessional style and general goofiness bring levity to an awkward topic: "erectile dysfunction" and the little blue pill that treats it.

Shot over the course of 18 months in New York City's Lower East Side, METHADONIA sheds light on the inherent flaws of legal methadone treatments for heroin addiction by profiling eight addicts, in various stages of recovery and relapse, who attend the New York Center for Addiction Treatment Services (NYCATS).

Extraordinary behind-the-scenes access reveals a drug company's fevered race to develop the first FDA-approved Viagra for women - and offers a humorous but sobering look inside the cash-fueled pharmaceutical industry.

Psychotropic drugs. It’s the story of big money-drugs that fuel a $330 billion psychiatric industry, without a single cure. The cost in human terms is even greater-these drugs now kill an estimated 42,000 people every year. And the death count keeps rising. Containing more than 175 interviews with lawyers, mental health experts, the families of victims and the survivors themselves, this riveting documentary rips the mask off psychotropic drugging and exposes a brutal but well-entrenched money-making machine. Before these drugs were introduced in the market, people who had these conditions would not have been given any drugs at all. So it is the branding of a disease and it is the branding of a drug for a treatment of a disease that did not exist before the industry made the disease.

Every year many new drugs come to market which offer hope to the sick and dying. This documentary film investigates just how far drug companies are prepared to go to get their drugs approved, what they will do to make sure they get the prices they want, and what happens when profits are put before people.

Americans consume 75% of the world’s prescription drugs. After losing his own brother to the growing epidemic of prescription drug abuse, documentarian Chris Bell sets out to demystify this insidious addiction. Bell’s examination into the motives of big pharma and doctors in this ever-growing market leads him to meet with experts on the nature of addiction, survivors with first-hand accounts of their struggle, and whistleblowers who testify to the dollar-driven aims of pharmaceutical corporations. Ultimately his investigation will point back to where it all began: his own front door.

Life is about choice. What we eat, what we read, who we elect; every day we make choices that determine how we want to live. But what if these choices are just an illusion? In an era where regulations and red tape rule every industry, where lobby groups and big businesses wield more influence than ever before, our daily choices have become increasingly limited. And with all our options so deliberately handpicked, are we really making a choice at all? Freedom From Choice examines the current state of life and personal choice today. Experts from many different fields offer a frank and startling look at the hidden limitations in our daily lives. Focusing on key areas such as food, medicine, finance, and media, Freedom From Choice provides viewers with a glimpse at the myriad of ways their lives are being dictated and tells us who stands to gain.

One in five Americans is taking a psychiatric drug, including millions of children. Pharmaceutical companies have over-hyped the benefits of these drugs, while hiding the risks and severe side effects including physiological dependence. "Medicating Normal" explores what happens when for- profit medicine intersects with human beings in distress.

A popular science film about the creation of a new drug, from the moment a chemist determines, based on the composition of a substance, that it might have medicinal effects, to the moment it finds itself in the patient's hand

Interviews with former drug dealers, over-prescribing doctors and DEA agents uncover a shocking truth of the pharmaceutical industry’s plan to target opioid sales to an impoverished community.